Similarly, a clinical trial in Egypt found no statistically significant difference in the number of participants reporting clinical symptoms of COVID-19 in the treatment groups (N=36) compared to the control group (N=18) after seven days of treatment with 200-400 mg bovine lactoferrin [60]. This evidence concerns the gene LTF and COVID-19.